Salspera
SciencePipelineOur DataTeamNews & PublicationsFAQContact
  1. FAQ
  2. ›
  3. Company

Who funded the Saltikva Phase 2 research?

The Saltikva Phase 2 study was funded through a group of private investors. Salspera, Inc. has been funded with private resources since its founding in 2017 (S-1/A No. 3).

  • Batist et al., Cancer Immunol Immunother 2026;75(2):60 ↗
  • Salspera, Inc. Form S-1/A No. 3, filed 2026-03-20 ↗
Last reviewed 2026-11-04
All questions in this categoryAll 65 questions
SalsperaA privately held, privately funded biopharma company developing Saltikva® and a pipeline of microbial immunotherapies for solid tumors.
CompanyScienceOur DataPipelineTeam
UpdatesNews & PublicationsFAQContactmedia@salspera.com
Legal© 2026 Salspera, Inc. All rights reserved. Saltikva® is a registered trademark of Salspera, Inc. Saltikva® is an investigational therapy and has not been approved by any regulatory authority. Clinical results are from a single-arm, non-randomized study. Statements about future plans are forward-looking.